(CTN News)- Moderna and Merck released additional encouraging three-year results regarding their experimental vaccine. Patients with the most lethal form of skin cancer receive this vaccine in combination with Keytruda. In a midstage trial, the vaccination was combined with Merck’s Keytruda, which demonstrated long-lasting efficacy and improved survival in patients with a fatal form of […]
The post Both Merck And Moderna Have Applied For Expedited FDA Approval. appeared first on CTN News – Chiang Rai Times.
Go to Source
Author: Salman Ahmad